DCTH (Delcath Corp) שולי רווח גולמי

Uninterrupted system assembly driven by inventory reserves supports the stability reflected in current gross margin levels for Delcath Systems, Inc. (DCTH). Revenues are based on the sale of equipment and chemotherapy disposable kits, while the implementation of protocols in oncology centers ensures consistent demand. The value of 87.60 shows the current magnitude of this financial indicator, confirming the efficiency of the Delcath Systems, Inc. (DCTH) operating model.
פילוחים אנליטיים ודוחות נתונים של חברת delcath.com (DCTH)

For the medtech sector specializing in unique liver chemoperfusion systems, gross margin serves as a key indicator of the efficiency of intellectual property monetization and market niche protection. This metric is calculated as the ratio of the difference between revenue and cost of goods sold to total sales; by analyzing historical gross margins, an investor assesses the ability of Delcath Systems, Inc. (DCTH) to maintain high procedure profitability through patent protection and FDA approval.